Skip to main content
Evenity 105 mg/1.17mL injection, solution by Amgen, Inc
Evenity, 105 mg/1.17mL, injection, solution Available on prescription only. Listed by Amgen, Inc.
Prescription only

Evenity

romosozumab-aqqg

Listed by Amgen, Inc

Strength
105 mg/1.17mL
Form
Injection, Solution
Route
Subcutaneous

What it contains

  • Romosozumab 105 mg/1.17mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Approval route BLA — biologic licence
NDC code 55513-509
FDA application BLA761062
RxNorm concept 2123184
Package sizes listed 1
Marketed since January 2026

Other products containing Romosozumab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Evenity

romosozumab-aqqg

Strength
105 mg/1.17mL
Form
Injection, Solution
Rx only

Amgen, Inc

Not stocked by us — reference only

Evenity

romosozumab-aqqg

Strength
105 mg/1.17mL
Form
Injection, Solution
Rx only

Amgen, Inc

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.